A framework for clinical care pathway renewal: an example from inflammatory bowel disease.

IF 3.9 3区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
K D Chappell, L Olayinka, R Sutton, C H Seow, J deBruyn, S V van Zanten, C Ma, B Halloran, L A Dieleman, K Wong, R Panaccione, K I Kroeker
{"title":"A framework for clinical care pathway renewal: an example from inflammatory bowel disease.","authors":"K D Chappell, L Olayinka, R Sutton, C H Seow, J deBruyn, S V van Zanten, C Ma, B Halloran, L A Dieleman, K Wong, R Panaccione, K I Kroeker","doi":"10.1186/s12874-025-02616-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Clinical care pathways (CCPs) contribute to standardized, high-quality care and reduce variation in healthcare delivery. However, CCPs must be regularly reviewed and updated to reflect current evidence-based clinical practice guidelines. In the literature, the development and implementation of CCPs is well described, but there is little to guide the process for renewal of CCPs as new evidence becomes available.</p><p><strong>Methods: </strong>We sought to develop a recurrent framework for CCP renewal and apply this to provincial established CCPs for inflammatory bowel disease (IBD). The proposed framework was guided by a review matrix stratified based on two factors: risk to change and clinical impact of the CCPs. An in-person CCP workshop was conducted to facilitate advisor engagement, establish consensus on the review process, and apply the review matrix to existing IBD CCPs. Attendees, including gastroenterologists, nurses, pharmacists, colorectal surgeons, and a family physician, were invited to offer feedback on the proposed framework and vote on the definitions associated with each level of the matrix. They then applied the framework to existing CCPs in two voting rounds.</p><p><strong>Results: </strong>A proposed framework for CCP renewal was drafted by a multidisciplinary leadership group and presented to 22 IBD stakeholders at the in-person workshop. After a discussion, attendees agreed the matrix should include four levels, based on either high or low risk to change and high or low clinical impact. Risk to change was defined as how quickly new evidence would evolve and render the CCP out of date, and clinical impact was defined as how important the CCP is to quality IBD care. Using the revised review matrix, the attendees were able to reach agreement regarding the level to be assigned to each existing CCP.</p><p><strong>Conclusions: </strong>The framework, based on risk to change and clinical impact is a valuable starting point to standardize the process of updating and renewing clinical pathways. Revising CCPs using our proposed framework ensures pathways are up-to-date and available to assist healthcare professionals in clinical decision-making. This framework can be adapted and customized to suit CCPs across healthcare disciplines and to facilitate the establishment of a renewal process.</p>","PeriodicalId":9114,"journal":{"name":"BMC Medical Research Methodology","volume":"25 1","pages":"173"},"PeriodicalIF":3.9000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239251/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Research Methodology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12874-025-02616-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Clinical care pathways (CCPs) contribute to standardized, high-quality care and reduce variation in healthcare delivery. However, CCPs must be regularly reviewed and updated to reflect current evidence-based clinical practice guidelines. In the literature, the development and implementation of CCPs is well described, but there is little to guide the process for renewal of CCPs as new evidence becomes available.

Methods: We sought to develop a recurrent framework for CCP renewal and apply this to provincial established CCPs for inflammatory bowel disease (IBD). The proposed framework was guided by a review matrix stratified based on two factors: risk to change and clinical impact of the CCPs. An in-person CCP workshop was conducted to facilitate advisor engagement, establish consensus on the review process, and apply the review matrix to existing IBD CCPs. Attendees, including gastroenterologists, nurses, pharmacists, colorectal surgeons, and a family physician, were invited to offer feedback on the proposed framework and vote on the definitions associated with each level of the matrix. They then applied the framework to existing CCPs in two voting rounds.

Results: A proposed framework for CCP renewal was drafted by a multidisciplinary leadership group and presented to 22 IBD stakeholders at the in-person workshop. After a discussion, attendees agreed the matrix should include four levels, based on either high or low risk to change and high or low clinical impact. Risk to change was defined as how quickly new evidence would evolve and render the CCP out of date, and clinical impact was defined as how important the CCP is to quality IBD care. Using the revised review matrix, the attendees were able to reach agreement regarding the level to be assigned to each existing CCP.

Conclusions: The framework, based on risk to change and clinical impact is a valuable starting point to standardize the process of updating and renewing clinical pathways. Revising CCPs using our proposed framework ensures pathways are up-to-date and available to assist healthcare professionals in clinical decision-making. This framework can be adapted and customized to suit CCPs across healthcare disciplines and to facilitate the establishment of a renewal process.

临床护理途径更新的框架:以炎症性肠病为例。
背景:临床护理路径(CCPs)有助于标准化、高质量的护理,并减少医疗保健服务的变化。然而,ccp必须定期审查和更新,以反映当前的循证临床实践指南。在文献中,CCPs的发展和实施得到了很好的描述,但是随着新证据的出现,很少有指导CCPs更新的过程。方法:我们试图建立一个CCP更新的复发性框架,并将其应用于省级建立的炎症性肠病(IBD) CCP。建议的框架由基于两个因素分层的评价矩阵指导:变更风险和CCPs的临床影响。进行了一次面对面的CCP研讨会,以促进顾问的参与,在审查过程中建立共识,并将审查矩阵应用于现有的IBD CCP。与会者,包括胃肠病学家、护士、药剂师、结直肠外科医生和一名家庭医生,被邀请对拟议的框架提供反馈,并对与矩阵的每个级别相关的定义进行投票。然后,他们在两轮投票中将该框架应用于现有的ccp。结果:一个多学科领导小组起草了CCP更新的拟议框架,并在现场研讨会上向22名IBD利益相关者提交了建议。经过讨论,与会者同意矩阵应该包括四个级别,基于高或低的改变风险和高或低的临床影响。变化风险被定义为新证据发展的速度和CCP过时的速度,临床影响被定义为CCP对IBD护理质量的重要性。使用修订后的评审矩阵,与会者能够就分配给每个现有CCP的级别达成一致。结论:基于变化风险和临床影响的框架是规范更新和更新临床路径过程的一个有价值的起点。使用我们提出的框架修改ccp确保路径是最新的,并可帮助医疗保健专业人员进行临床决策。可以对该框架进行调整和定制,以适应医疗保健学科的ccp,并促进更新流程的建立。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Medical Research Methodology
BMC Medical Research Methodology 医学-卫生保健
CiteScore
6.50
自引率
2.50%
发文量
298
审稿时长
3-8 weeks
期刊介绍: BMC Medical Research Methodology is an open access journal publishing original peer-reviewed research articles in methodological approaches to healthcare research. Articles on the methodology of epidemiological research, clinical trials and meta-analysis/systematic review are particularly encouraged, as are empirical studies of the associations between choice of methodology and study outcomes. BMC Medical Research Methodology does not aim to publish articles describing scientific methods or techniques: these should be directed to the BMC journal covering the relevant biomedical subject area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信